(19 days)
CL-R211 (CL-R211xxxxx) is intended to be used in displaying medical images for diagnosis by trained medical practitioners or certified personnel. It is not meant to be used in digital mammography.
2MP Color LCD Monitor CL-R211. Resolution: 1600 x 1200 (landscape), 1200 x 1600 (portrait). DVI (digital interface) and DisplayPort (digital interface).
This document describes the JVC Kenwood 2MP Color LCD Monitor CL-R211 (K182539), a medical display intended for diagnostic viewing of medical images. The acceptance criteria and supporting study details are as follows:
1. Acceptance Criteria and Reported Device Performance:
| Acceptance Criteria | Reported Device Performance | Basis/Standard |
|---|---|---|
| Luminance Response: Less than ±10% | Confirmed | AAPM-TG18 4.3 |
| Angular Dependencies: More than angle of 20° LR'δ, θ ≥ 175, kδ, θ ≤ 30% | Confirmed | AAPM-TG18 4.4 |
| Luminance Uniformity: Less than 30% | Confirmed | AAPM-TG18 4.4.4 |
| Pixel Defects / Fault: Class II or more | Confirmed | ISO13406-2 |
| Artifacts: No flicker, ringing, ghosting, and image sticking. | Confirmed (By visible check) | N/A (Visible Check) |
| Chromaticity: Δ(u', v') ≤ 0.01 measured at 80% Lmax | Confirmed | AAPM-TG18 4.8.4 |
| Power On Luminance Drift: ΔLmax ≤ ±10% within 60 seconds. | Confirmed | N/A |
| Reflection: (Criteria based on AAPM-TG18 4.2) | Confirmed | AAPM-TG18 4.2 |
2. Sample size used for the test set and the data provenance:
The provided document does not contain information regarding a specific "test set" and its sample size or data provenance in the context of clinical image data. The performance criteria relate to the technical specifications and physical characteristics of the monitor itself. The studies mentioned are standard performance tests for display monitors, not clinical trials with patient data.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
This information is not applicable. The device is a display monitor, and its performance is evaluated against technical specifications and established standards (like AAPM-TG18 and ISO13406-2), not against clinical ground truth established by medical experts for diagnostic accuracy.
4. Adjudication method for the test set:
This information is not applicable for the reasons stated above.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
This information is not applicable. The device is a display monitor, not an AI-powered diagnostic tool. Therefore, no MRMC study or AI assistance evaluation was performed or is relevant to its intended use.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:
This information is not applicable for the reasons stated above. The device is a display monitor, not an algorithm.
7. The type of ground truth used:
The "ground truth" for the device's performance is based on established technical standards and measurements. For example, for luminance response, the ground truth is the specified deviation from a target based on AAPM-TG18 guidelines; for pixel defects, it's the ISO13406-2 standard. For artifacts, it's a "visible check" for the absence of defects.
8. The sample size for the training set:
This information is not applicable. The device is a hardware product (display monitor), not a machine learning algorithm that requires a training set.
9. How the ground truth for the training set was established:
This information is not applicable for the reasons stated above.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image shows the logos of the Department of Health and Human Services and the Food and Drug Administration (FDA). The Department of Health and Human Services logo is on the left, and the FDA logo is on the right. The FDA logo includes the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text. The logos are simple and professional in appearance.
JVC Kenwood Corporation c/o Masafumi Yugami Manager 3-12, Moriya-cho, Kanagawa-ku Yokohama, Kanagawa 221-0022 JAPAN
October 3, 2018
Re: K182539
Trade/Device Name: 2MP Color LCD Monitor CL-R211 Regulation Number: 21 CFR 892.2050 Regulation Name: Picture Archiving And Communications System Regulatory Class: Class II Product Code: PGY Dated: September 12, 2018 Received: September 14, 2018
Dear Masafumi Yugami:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You mav, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be avare that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
{1}------------------------------------------------
requirements, including, but not limited to: registration and listing (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.html; good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
Michael D. O'Hara
for Robert A. Ochs. Ph.D. Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
510(k) Number (if known)
Device Name 2MP Color LCD Monitor CL-R211
Indications for Use (Describe)
CL-R211 (CL-R211xxxxx) is intended to be used in displaying medical images for diagnosis by trained medical practitioners or certified personnel.
It is not meant to be used in digital mammography.
| Type of Use ( Select one or both, as applicable ) | ||
|---|---|---|
| Prescription Use (Part 21 CFR 801 Subpart D) Over-The-Counter Use (21 CFR 801 Subpart C) | Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
| Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete
time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Druq Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
JVCKENWOOD
510(k) SUMMARY
| Submitted Information: | JVC KENWOOD Corporation3-12, Moriya-cho, Kanagawa-ku,Yokohama-shi, Kanagawa, 221-0022 Japan | |
|---|---|---|
| Contact Person: | Masafumi Yugami, ManagerEmail: yugami.masafumi@jvckenwood.comTel: +81-258-24-6611Fax: +81-258-24-6617 | |
| Date Prepared: | September 12, 2018 | |
| Device Name: | 2MP Color LCD MonitorCL-R211 | |
| Common Name: | CL-R211(CL-R211xxxxx) | |
| Classification Name: | Class II(Part 892 Radiology DevicesSec. 892.2050 Picture Archiving and Communication System) | |
| Predicate Device: | 21.3 inch (54cm) Color LCD Monitor CCL214(CL21214/ K161895) | |
| Device Description: | CL-R211 : 1600 x 1200 (landscape), 1200 x 1600 (portrait)DVI (digital interface) and DisplayPort (digital interface) | |
| Intended Use: | CL-R211 is intended to be used in displaying and viewing medicalimages for diagnosis by trained medical practitioners or certifiedpersonnel.It is not meant to be used in digital mammography. | |
| Substantial Equivalence: | CL-R211 shares the same technical characteristics, application, andintended use as our predicate device CCL214 (CL21214 / K161895) |
JVC KENWOOD Corporation
{4}------------------------------------------------
| Technical Specification |
|---|
| 1. Luminance Response[SPEC] Less than $\pm$ 10% based on AAPM-TG18 4.3. |
| 2. Angular Dependencies[SPEC] More than angle of 20° LR' $\delta$ , $\theta$ ≥ 175, k $\delta$ , $\theta$ ≤ 30% based on AAPM-TG18 4.4. |
| 3. Luminance Uniformity[SPEC] Less than 30% based on AAPM-TG18 4.4.4 |
| 4. Pixel Defects / Fault[SPEC] Class II or more. ISO13406-2 |
| 5. Artifacts- phase/clock issues flicker- miscellaneous including ringing, ghosting, image sticking[SPEC] By visible check, no flicker, ringing, ghosting and image sticking. |
| 6. Chromaticity Measurement of 5%, 50%, 95% Level |
| 7. Chromaticity[SPEC] $\triangle$ (u' , v' ) ≤ 0.01 measured at 80% Lmax based on AAPM-TG18 4.8.4 |
| 8. Power On Luminance Drift[SPEC] $\triangle$ Lmax≤ $\pm$ 10% within 60 seconds.$\triangle$ Lmax : the deviation between the target maximum luminance and the measured luminance. |
| 9. ReflectionBased on AAPM-TG18 4.2. |
{5}------------------------------------------------
Substantial Equivalence Comparison
| CCL214 (CL21214) | CL-R211(CL-R211xxxxx) | |
|---|---|---|
| 510(k) Number | K161895 | Not Known |
| Resolution or Matrix Size | 2MP(1200 x 1600) | 2MP(1200 x 1600) |
| Screen Technology | TFT Color LCD Panel (IPS) | TFT Color LCD Panel (IPS) |
| Backlighting | LED | LED |
| Maximum Luminance | 500 cd/m2 typ. | 500 cd/m2 typ. |
| DICOM | ||
| Calibrated Luminance | 250 cd/m² | 250 cd/m² |
| Viewing Angle | CR>10:1Horizontal: Typ.178 Vertical: Typ.178 | CR>10:1Horizontal: Typ.178 Vertical: Typ.178 |
| Display Area | Horizontal: 432.0mm, Vertical: 324.0mm | Horizontal: 432.0mm, Vertical: 324.0mm |
| Response Time (typical) | 10% – 90%Ton 8ms Typ. Toff 8ms Typ. | 10% – 90%Ton 8ms Typ. Toff 8ms Typ. |
| Aspect Ratio | 3:4 | 3:4 |
| Pixel Pitch | Horizontal: 0.270mm, Vertical: 0.270mm | Horizontal: 0.270mm, Vertical: 0.270mm |
| Contrast Ratio | 1200:1 | 1800:1 |
| Grayscale Tones | 10-bit (DisplayPort): 1,024from a palette of 65,473 tones8-bit: 256 from a palette of65,473 tones | 10-bit (DisplayPort): 1,024from a palette of 65,473 tones8-bit: 256 from a palette of65,473 tones |
| Non-Uniformity | ||
| Compensation | Uniformity correction System | Uniformity correction System |
| Input Video Signal | DVI-D 24-pin connector, DisplayPort connector | DVI-D 24-pin connector, DisplayPort connector |
| USB Ports / Standard | USB: upstream port (x 1), downstream port (x 2)Ver 2.0 | USB: upstream port (x 1), downstream port (x 2)Ver 2.0 |
| CCL214 (CL21214) | CL-R211(CL-R211xxxxx) | |
| Scanning Frequency | DVIHorizontal:74.1KHz, Vertical: 60Hz (Landscape)Horizontal:98.1KHz, Vertical: 60Hz (Portrait)DisplayPortHorizontal:75.0KHz, Vertical: 60Hz (Landscape)Horizontal:99.0KHz, Vertical: 60Hz (Portrait) | DVIHorizontal:74.1KHz, Vertical: 60Hz (Landscape)Horizontal:98.1KHz, Vertical: 60Hz (Portrait)DisplayPortHorizontal:75.0KHz, Vertical: 60Hz (Landscape)Horizontal:99.0KHz, Vertical: 60Hz (Portrait) |
| Maximum Image Clock | 162MHz | 162MHz |
| Rated | AC100-240V, 50/60Hz1.4 - 0.7A | AC100-240V, 50/60Hz2.2 - 1.1A |
| Luminance Calibration(Optional) | SoftwarePhoto Sensor (optional): X-Rite i1Display | SoftwarePhoto Sensor (optional): X-Rite i1Display |
| Sensor | Built-in Front SensorBuilt-in Ambient Light SensorNone | Built-in Front SensorBuilt-in Ambient Light SensorBuilt-in Human presence sensor |
| Safety Standards | ANSI/AAMI ES60601-1, CAN/CSA C22.2 No. 60601-1,FCC (Class B), ICES-003 (Class B),MDD/CE, VCCI-B (Class B) | ANSI/AAMI ES60601-1, CAN/CSA C22.2 No. 60601-1,FCC (Class B), ICES-003 (Class B),MDD/CE, VCCI-B (Class B) |
| Weight & Dimension | Net: 11.1kg367.0(w) x 521.9 – 583.4(H) x 220(D) mmPacked: Approx.14.0kg470(w) x 670(H) x 340.0(D) mm | Net: 8.9kg361.5(w) x 517 – 612(H) x 196.5(D) mmPacked: Approx.11.9kg585(w) x 580(H) x 285(D) mm |
{6}------------------------------------------------
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).